Home / News / India News / Article /
Serum Institute of India applies to DCGI to manufacture Covid-19 vaccine Sputnik V
Updated On: 03 June, 2021 12:37 PM IST | Pune | PTI
Russia's Sputnik V vaccine is currently being manufactured in India by Dr Reddy's Laboratories.
Listen to this article :

Photo used for representational purpose. Pic/AFP
The Serum Institute of India (SII) has applied to the Drug Controller General of India (DCGI) seeking permission to manufacture Covid-19 vaccine Sputnik V in the country, sources said on Thursday.
The Pune-based firm has also sought approval for test analysis and examination.
How do you like the new new mid-day.com experience? Share your feedback and help us improve.

